4 in 10 Overweight Americans Say They’ll Try a GLP-1 Pill in 2026

A new Sunlight.com survey finds that about 4 in 10 overweight Americans say they’re likely to try a GLP-1 weight-loss pill in 2026, and nearly half of those interested would prefer an oral option over injections, as barriers like needle aversion, cost, and side effects continue to influence treatment choices.

This rising interest in pill-based weight-loss solutions highlights a growing consumer market that could shape health, wellness, and food- and lifestyle-related messaging by emphasizing convenience, accessibility, and lifestyle compatibility as key decision factors.